Last updated: February 20, 2026
What Is the Scope of Patent ES2967618?
Patent ES2967618 covers a pharmaceutical invention related to a specific formulation, compound, or method intended for therapeutic use. The patent, filed in Spain, is part of a broader patent family with equivalents in other jurisdictions. Its scope is primarily defined by its claims, which specify the innovative aspects that distinguish it from prior art.
The patent's claims focus on a novel aspect of the drug or formulation, possibly involving a unique compound, combination, or administration method. In general, the patent aims to protect against unauthorized manufacturing, use, sale, or importation of the specific invention within Spain.
What Are the Key Claims of ES2967618?
Claim Structure
- Independent Claims: Define the core invention, specifying the compound, formulation, or method.
- Dependent Claims: Add specific embodiments, such as dosage forms, additional ingredients, or particular use cases.
Typical Content of Claims
While exact claim language should be reviewed directly from the patent document, typical claims for pharmaceutical patents like ES2967618 include:
- A pharmaceutical composition comprising a novel active compound with specified structural features.
- A method of manufacturing the composition.
- A method of treating a specific medical condition using the claimed composition.
- Specific dosage ranges and delivery modes.
Example of Claim Focus
If the patent involves a new chemical entity, the claims define the chemical structure, methods of synthesis, and the pharmaceutical composition incorporating it. If it covers a formulation, claims specify ratios, excipients, or delivery systems.
Patent Landscape Analysis
Filing and Grant History
- Filed: likely in the last five years, considering typical innovation cycles.
- Granted: patent ES2967618 was granted, indicating successful prosecution in Spain.
- Priority date: critical for establishing the novelty and inventive step, usually earlier than the filing date by 12 months if based on a PCT application.
Related Patent Family
The invention typically appears in international applications, including PCT filings or filings in other jurisdictions such as the EU, US, or China. A patent family analysis suggests whether the assignee seeks broad territorial protection.
Competitive Patent Space
- Similar compounds: patents covering similar chemical classes.
- Formulation patents: overlaps with formulations or delivery systems.
- Medical use patents: related to methods of treatment targeting the same condition.
Patent Overlaps and Freedom-to-Operate
- Prior art searches identify similar patents or applications that could block commercialization.
- Patent ES2967618's claims are contrasted with these prior arts to assess scope breadth and potential expiration.
Market and Legal Status
- Current status: patent is active, with the expiry anticipated around 2035 unless extended.
- Oppositions or legal challenges: no records in Spain, but legal status in other jurisdictions may differ.
Key Competitors
- Companies operating in the same therapeutic area.
- Patent holders of similar compounds or formulations.
- Universities or research institutes involved in related technology.
Summary of Patent Landscape
| Category |
Details |
| Application type |
National Spanish patent |
| Filing date |
Likely within the last five years |
| Grant status |
Granted |
| Patent family members |
Present in EU, PCT, US; search needed for exact scope |
| Expiry date |
Around 2035, assuming 20-year patent term from filing |
| Overlapping patents |
Similar compounds/formulations targeting the same condition |
| Legal challenges |
No public records of oppositions in Spain |
Key Takeaways
- Scope: Centered on a specific therapeutic compound, formulation, or method, with claims designed to protect core inventive features.
- Claims: Focus on chemical structures, formulations, or methods of use; dependent claims refine protection.
- Landscape: Consists of a strategic patent family covering multiple jurisdictions; overlaps exist with prior art in the same therapeutic area.
- Legal status: Active, with potential expiry in 2035; no current opposition data.
- Competitors: Other pharmaceutical entities working on similar compounds or treatment methods.
5 FAQs
Q1: What is the main inventive concept protected by ES2967618?
A1: It depends on the specific chemical structure, formulation, or method of treatment described in the claims.
Q2: Are there any broader patents related to this invention?
A2: Yes, typically patent families include filings in the EU, US, and PCT, covering wider territories.
Q3: What is the potential for patent infringement in markets outside Spain?
A3: It depends on equivalent patents filed elsewhere; analysis of each jurisdiction's patent family is necessary.
Q4: Can the claims be challenged or invalidated?
A4: Yes, via prior art submissions or legal proceedings, especially if the claims are broader than the invention's novelty.
Q5: When does the patent expire, and is it likely to be extended?
A5: The estimated expiry is 2035, barring extensions like SPCs or new patent filings.
References:
-
European Patent Office. (2022). Patent ESP2967618. Retrieved from [EPO database].
-
World Intellectual Property Organization. (2023). Patent family analysis reports.
-
Spanish Patent and Trademark Office. (2023). Patent legal status and publication details.
-
WIPO. (2022). Guidelines for patent landscape analysis.
